blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1776587

EP1776587 - USE OF C3A AND DERIVATIVES THEREOF AS BIOMARKER FOR COLORECTAL ADENOMA AND/OR CARCINOMA ; DIAGNOSIS METHODS AND ASSAYS USING THE SAME [Right-click to bookmark this link]
Former [2007/17]USE OF C3A AND DERIVATIVES THEREOF AS A BIOMARKER FOR COLORECTAL ADENOMA AND/OR CARCINOMA; DIAGNOSIS METHOD AND TEST SYSTEM USING THE SAME
[2008/16]
StatusNo opposition filed within time limit
Status updated on  06.11.2009
Database last updated on 05.10.2024
Most recent event   Tooltip30.09.2011Lapse of the patent in a contracting state
New state(s): CY		published on 02.11.2011  [2011/44]
Applicant(s)For all designated states
Indivumed GmbH
Orchideenstieg 14
22297 Hamburg / DE
[2007/17]
Inventor(s)01 / JUHL, Hartmut
Nienstedtener Strasse 18
22609 Hamburg / DE
02 / DAVID, Kerstin
Chateauneufstrasse 10
20535 Hamburg / DE
03 / FENTZ, Anne-Kristin
Heymannstrasse 10a
20253 Hamburg / DE
 [2008/37]
Former [2007/17]01 / JUHL, Hartmut
Kurt-Küchler-Strasse 5
22609 Hamburg / DE
02 / DAVID, Kerstin
Chateauneufstrasse 10
20535 Hamburg / DE
03 / FENTZ, Anne-Kristin
Heymannstrasse 10a
20253 Hamburg / DE
Representative(s)Louis Pöhlau Lohrentz
Patentanwälte
Postfach 30 55
90014 Nürnberg / DE
[N/P]
Former [2007/17]LOUIS, PÖHLAU, LOHRENTZ
Patentanwälte Postfach 30 55
D-90014 Nürnberg / DE
Application number, filing date05772471.811.08.2005
[2007/17]
WO2005EP08742
Priority number, dateWO2004EP0912413.08.2004         Original published format: PCT/EP2004/009124
[2007/17]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2006053592
Date:26.05.2006
Language:EN
[2006/21]
Type: A1 Application with search report 
No.:EP1776587
Date:25.04.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 26.05.2006 takes the place of the publication of the European patent application.
[2007/17]
Type: B1 Patent specification 
No.:EP1776587
Date:31.12.2008
Language:EN
[2009/01]
Type: B9 Corrected patent specification 
No.:EP1776587
Date:16.09.2009
[2009/38]
Search report(s)International search report - published on:EP26.05.2006
ClassificationIPC:G01N33/574
[2007/17]
CPC:
G01N33/57419 (EP,KR,US); G01N33/57488 (EP,KR,US); G01N33/78 (EP,KR,US);
G01N2333/76 (EP,KR,US); G01N2800/52 (EP,KR,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/17]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:VERWENDUNG VON C3A UND DERIVATEN ALS BIOMARKER FÜR KOLOREKTALADENOM UND/ODER -KARZINOM ; NACHWEISVERFAHREN UND TESTSYSTEM DAMIT[2008/16]
English:USE OF C3A AND DERIVATIVES THEREOF AS BIOMARKER FOR COLORECTAL ADENOMA AND/OR CARCINOMA ; DIAGNOSIS METHODS AND ASSAYS USING THE SAME[2008/16]
French:UTILISATION DE C3A ET DÉRIVÉS COMME BIOMARQUEURS D'ADENOME COLORECTAL ET/OU DE CARCINOME COLORECTAL ; PROCÉDÉS ET TESTS DIAGNOSTIQUES LES UTILISANT[2008/16]
Former [2007/17]VERWENDUNG VON C3A UND DERIVATEN DAVON ALS BIOMARKER FÜR KOLOREKTALES ADENOM UND/ODER KARZINOM, DIAGNOSEVERFAHREN UND TESTSYSTEM DAMIT
Former [2007/17]USE OF C3A AND DERIVATIVES THEREOF AS A BIOMARKER FOR COLORECTAL ADENOMA AND/OR CARCINOMA; DIAGNOSIS METHOD AND TEST SYSTEM USING THE SAME
Former [2007/17]UTILISATION DE LA C3A ET DE DÉRIVÉS DE CELLE-CI COMME BIOMARQUEUR POUR UN ADENOME COLORECTAL ET/OU UN CARCINOME COLORECTAL ; PROCÉDÉ DE DIAGNOSTIC ET SYSTÈME DE TEST UTILISANT CEUX-CI
Entry into regional phase17.01.2007National basic fee paid 
17.01.2007Designation fee(s) paid 
17.01.2007Examination fee paid 
Examination procedure01.06.2006Request for preliminary examination filed
International Preliminary Examining Authority: EP
17.01.2007Examination requested  [2007/17]
26.06.2007Despatch of a communication from the examining division (Time limit: M06)
18.12.2007Reply to a communication from the examining division
04.07.2008Communication of intention to grant the patent
24.10.2008Fee for grant paid
24.10.2008Fee for publishing/printing paid
Opposition(s)01.10.2009No opposition filed within time limit [2009/50]
Fees paidRenewal fee
05.07.2007Renewal fee patent year 03
28.03.2008Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY31.12.2008
FI31.12.2008
LT31.12.2008
LV31.12.2008
IS30.04.2009
LU11.08.2009
MC31.08.2009
[2011/44]
Former [2011/22]FI31.12.2008
LT31.12.2008
LV31.12.2008
IS30.04.2009
LU11.08.2009
MC31.08.2009
Former [2010/16]FI31.12.2008
LT31.12.2008
LV31.12.2008
IS30.04.2009
MC31.08.2009
Former [2009/52]FI31.12.2008
LT31.12.2008
LV31.12.2008
IS30.04.2009
Former [2009/27]FI31.12.2008
LV31.12.2008
Cited inInternational search[Y]US2001023066  (KINDERS ROBERT J [US], et al) [Y] 1-5,8-15 * paragraphs [0001] , [0010] - [0015] - [0018] , [0020] - [0022] - [0046] , [0047] , [0065] , [0067] , [0095] - [0120] - [0147] - [0173] * * claims 1,2 *;
 [A]US6682740  (ERDEI ANNA [HU], et al) [A] 1-26* the whole document *;
 [XY]WO2005008251  (PRAECIS PHARM INC [US], et al) [X] 18,21 * page 48, line 1 - page 57, line 29 * * claim 27 * * page 10, line 29 - line 32 * * tables 1,2 * * claims 1-35 * [Y] 1-6,8-16,19,22,24,25;
 [XY]  - SWAHN M. ET AL., "Complement activation in ovarian cancer.", EUR. J. CANCER, (200104), vol. 37, page S320, XP004478426 [X] 18 * the whole document * [Y] 1-6,8-16,19,22,24,25

DOI:   http://dx.doi.org/10.1016/S0959-8049(01)81677-4
 [XA]  - BURGER R. ET AL., "The C terminus of the anaphylatoxin C3a generated upon complement activation represents a neoantigenic determinant with diagnostic potential.", J. IMMUNOL., (19880715), vol. 141, no. 2, pages 553 - 558, XP002363694 [X] 18 * page 554, column 1, paragraph 4 * * page 554, column 2, paragraph 3 * * the whole document * [A] 1-17,19-26
 [XA]  - ZILOW G. ET AL., "Quantitation of the anaphylatoxin C3a in the presence of C3 by a novel sandwich ELISA using monoclonal antibody to a C3a neoepitope.", J. IMMUNOL. METH., (1989), vol. 121, pages 261 - 268, XP002314357 [X] 18 * abstract * * page 262, column 1, line 24 - line 39 * * the whole document * [A] 1-17,19-26

DOI:   http://dx.doi.org/10.1016/0022-1759(89)90169-5
 [A]  - ANDOH A. ET AL., "Detection of complement C3 and factor B gene expression in normal colorectal mucosa, adenomas and carcinomas.", CLIN. EXP. IMMUNOL., (1998), vol. 111, pages 477 - 483, XP002363695 [A] 1-26 * the whole document *

DOI:   http://dx.doi.org/10.1046/j.1365-2249.1998.00496.x
 [A]  - SARBINOWSKI R. ET AL., "Plasma concentration of procalcitonin and systemic inflammatory response syndrome after colorectal surgery.", ACTA ANAESTHESIOL. SCAND., (200502), vol. 49, no. 2, pages 191 - 196, XP002363696 [A] 1-26 * the whole document *

DOI:   http://dx.doi.org/10.1111/j.1399-6576.2004.00565.x
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.